Frontlight ResearchEarly access
Taking people in SpainPhase 2
Tests chemotherapy before surgery for locally advanced colon cancer
Tests chemotherapy given before surgery in adults with locally advanced colon cancer.
Key facts
- Who runs it
- Clinica Universidad De Navarra
- Where
- Badajoz, Burgos, Galdakao, León, Lugo, Madrid, Murcia, Oviedo, Palma, Pamplona, Salamanca, Talavera De La Reina, Valencia, Valladolid, and Vigo, SpainSee the 18 sites
- Registry title
- ANALYSIS OF EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED COLON CANCER.
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 238 people, planned
- Started
- 30 Jan 2025
- Expected to end
- 31 Jul 2029
- Type of study
- Interventional
- Record updated
- 30 January 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with locally advanced colon cancer that can be removed by surgery and has not spread to other organs.
- Age
- Over 18 years
- Sex
- All sexes can join
- Disease stage
- Colon adenocarcinoma confirmed by tissue test. The tumor is T4, or T3 growing more than 5 mm through the bowel wall on CT. Lymph nodes may or may not be involved. No spread to other organs (M0). Surgery with the aim of removing all the cancer must be planned.
- Biomarker or test result
- People with microsatellite instability cannot join.
Main reasons for not taking part
- Rectal cancer
- Distant metastasis or cancer spread inside the abdominal lining
- Another cancer in the last 5 years, except melanoma
- Intestinal obstruction
- Pregnancy or breastfeeding
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Histological confirmation of colon adenocarcinoma
- Radiologically resectable disease
- Who are going to undergo elective surgery with curative intent (R0)
- Patients of both sexes aged over 18 years
- Good general condition of the patient (Karnofsky>60% or ECOG<2)
- Analysis at the time of inclusion with hemoglobin levels >10 g/dL; Leukocytes >3.0 109/L, Platelets > 100,000, Glomerular Filtration >50 ml/min and Total Bilirubin <25 micromol/l
- Absence of contraindication for chemotherapy
- Acceptance and signing of the Informed Consent
- Radiological signs, evaluated by CT, of T4 or T3 tumor infiltration >5 mm of transmural invasion
- With or without lymph node involvement by CT
- Without metastatic involvement in other organs (M0)
Who cannot take part
- Significant comorbidity, uncontrolled angina or history of acute myocardial infarction in the last 6 months
- Personal history of another neoplasm in the last 5 years, except for melanoma
- Uncontrolled infection
- Rectal cancer (< 15 cm from the anal verge or below the peritoneal reflection)
- Refusal to participate or give written consent
- Inability, at the discretion of the researcher, to understand the purpose of the study or comply with its procedures
- Pregnancy or breastfeeding
- Peripheral neuropathy > grade 1
- Presence of distant metastasis or peritoneal carcinomatosis
- Intestinal obstruction
- Existence of microsatellite instability
Where in Spain
- Hospital Universitario de BadajozBadajoz, SpainTaking people
- Hospital Universitario De BurgosBurgos, SpainTaking people
- Hospital de Galdakao-UsansoloGaldakao, SpainTaking people
- Hospital Universitario De LeonLeón, SpainTaking people
- Hospital Universitario Lucus AugustiLugo, SpainTaking people
- Clinica Universidad de NavarraMadrid, SpainTaking people
- Hospital Central de la Defensa Gómez UllaMadrid, SpainTaking people
- Hospital Universitario Infanta LeonorMadrid, SpainTaking people
- Hospital Universitario La PazMadrid, SpainTaking people
- University Clinical Hospital Virgen De La ArrixacaMurcia, SpainTaking people
- Hospital Universitario Central De AsturiasOviedo, SpainTaking people
- Hospital Son LlatzerPalma, SpainTaking people
- Clínica Universidad de navarraPamplona, SpainTaking people
- Hospital Universitario De SalamancaSalamanca, SpainTaking people
- Hospital Nuestra Senona Del PradoTalavera De La Reina, SpainTaking people
- Hospital Clinico Universitario de ValenciaValencia, SpainTaking people
- Hospital Universitario Rio HortegaValladolid, SpainTaking people
- Hospital Alvaro CunqueiroVigo, SpainTaking people
About the trial
What the trial wants to find out
To determine if the proposed treatment with neoadjuvant chemotherapy, surgery and complementary chemotherapy increases Disease-Free Survival (DFS) at 2 years postoperatively, compared to the standard treatment, surgery and complementary chemotherapy.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Official title
- ANALYSIS OF EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED COLON CANCER.
- Plain-language title
- Tests chemotherapy before surgery for locally advanced colon cancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 30 January 2025